Skip to main content
Respiratory Medicine Obstructive Lung Diseases

Obstructive Lung Diseases

Mirtazapine ineffective for breathlessness

Breathlessness is not eased by mirtazapine treatment in individuals with chronic obstructive pulmonary disease, interstitial lung diseases, or both.

Read more

Editor's Choice

High- may beat low-intensity NPPV for avoiding COPD intubation

High- better than low-intensity noninvasive positive pressure ventilation for reducing the need for endotrachial intubation in patients with COPD and persistent hypercapnia.

24-hour oxygen no more effective than 15-hour for severe hypoxia 

Long-term, 24-hour oxygen therapy for severe hypoxia does not significantly reduce the risk for hospitalization or death compared with a 15 hour per day regimen.

Novel antihyperglycemic agents and respiratory function

GLP-1 receptor agonists and SGLT2 inhibitors have established antidiabetic and cardiovascular benefits, but could they also improve respiratory function in people with type 2 diabetes?

Air pollution worsens respiratory conditions

High ambient air pollution can worsen respiratory conditions and increase the need for hospitalization.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

  • Live
  • Webinar | 03-12-2024 | 19:00 (CET)

LIVE: Tuesday, 3 December 2024, 19:00-20:30 (CET)

Join us for an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies. 

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Reserve your place

Case Studies

Remission of eosinophilic esophagitis in an elderly patient treated with benralizumab

A case of EoE complicated by bronchial asthma in an elderly patient. The EoE did not respond to conventional therapy, but improved rapidly after benralizumab was introduced and did not recur after it was discontinued.

Superior vena cava syndrome induced by COPD

Superior vena cava (SVC) syndrome occurs when the SVC is either partially or completely obstructed. In this case of an elderly patient with dyspnea, a thoracic CT showed SVC caused by lung hyperinflation due to chronic obstructive pulmonary disease. 

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now

Current Reviews

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Asthma and cardiovascular disease (CVD) often co-exist. When a patient has both conditions, management requires an approach that addresses the unique challenges of each condition separately, while also considering their potential interactions.

Can Physicochemical Properties Alter the Potency of Aeroallergens? Part 1 – Aeroallergen Protein Families

Respiratory allergies (RA) are conditions caused by the hypersensitivity of the immune system to certain allergens in the environment. They are known to be caused by shared sources of allergens and to induce similar clinical expression. However …

Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis

The EQ-5D is a widely used instrument for measuring health-related quality of life (HRQoL). It comprises a health descriptive system and a visual analog scale (EQ VAS). The health descriptive system includes a five-item classifier that describes …

Ensifentrine: First Approval

Ensifentrine, an inhaled, selective phosphodiesterase (PDE) 3 and PDE4 inhibitor, is being developed by Verona Pharma plc for the treatment of respiratory diseases, including chronic obstructive pulmonary disease (COPD). In June 2024, ensifentrine …

CME & eLearning

SPONSORED

Webinar

Enhance your understanding of COPD with type 2 inflammation and learn about the evolving treatment landscape, in this webinar tailored for pulmonologists and healthcare professionals with an interest in respiratory medicine.

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare

Infographic

This expert-led infographic explains how to recognize and manage COPD exacerbations and explores the impact of these exacerbations at the patient and physician level.

Supported by:
  • Sanofi and Regeneron
Developed by: Springer Healthcare

Further Reading

Neonatal and early infancy antibiotic exposure is associated with childhood atopic dermatitis, wheeze and asthma

Antibiotics are frequently administered in the neonatal period and early infancy. Little is known about the long-term health consequences of early life antibiotic exposure. The objective is to investigate the association between neonatal and early …

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Asthma and cardiovascular disease (CVD) often co-exist. When a patient has both conditions, management requires an approach that addresses the unique challenges of each condition separately, while also considering their potential interactions.

Simultaneous incisional hernia repair and colorectal surgery: one or two-step procedure?

Incisional hernia has been described in 12.8% of patients after abdominal surgery, although some risk factors can increase that percentage and aggravate the described recurrence rates of 23–50% after hernia repair [ 1 ]. Some patients who require …

Muscle endurance, neuromuscular fatigability, and cognitive control during prolonged dual-task in people with chronic obstructive pulmonary disease: a case–control study

Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by airflow limitation associated with an abnormal inflammatory response of the lungs (Celli et al. 2004 ). In addition to its impact on lung function, COPD can also …

Related topics